Jun 11, 2026
1079:945
For every 945 shares held, investors received 1079. The price per share adjusted from $5.14 to $4.50.
The split itself did not change the total investment value.
AlzeCure Pharma AB (STO:ALZCUR) operates in the Biotechnology industry.
AlzeCure Pharma AB company overviewAlzeCure Pharma AB's most recent stock split was on June 11, 2026. It was a 1079-for-945 forward split, so shareholders received 1079 shares for every 945 they held.
AlzeCure Pharma AB (STO:ALZCUR) has split its stock 5 times: a 509-for-494 split on March 3, 2022, a 195-for-193 split on December 1, 2022, a 123-for-116 split on April 26, 2024, a 582-for-553 split on July 3, 2025, and a 1079-for-945 split on June 11, 2026.
AlzeCure Pharma AB has split its stock 5 times. This history records 5 forward splits between March 3, 2022 and June 11, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In AlzeCure Pharma AB's 1079-for-945 split on June 11, 2026, every 945 shares became 1079 shares.
AlzeCure Pharma AB has not announced a new split in our records. Its most recent split was on June 11, 2026, less than a year ago. Companies announce splits in advance, and any new STO:ALZCUR split will appear on this page.
Already premium?